Sami Hraiech Selected Research

Neuromuscular Blocking Agents

12/2020	Myorelaxants in ARDS patients.
7/2020	Factors Associated With Pulmonary Embolism Among Coronavirus Disease 2019 Acute Respiratory Distress Syndrome: A Multicenter Study Among 375 Patients.
12/2017	How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study.
7/2017	Sedation and neuromuscular blocking agents in acute respiratory distress syndrome.
3/2017	Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome.
12/2014	The use of paralytics in patients with acute respiratory distress syndrome.
7/2013	Pharmacological interventions in acute respiratory distress syndrome.
10/2012	The role of neuromuscular blockers in ARDS: benefits and risks.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sami Hraiech Research Topics

Disease

17	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021 - 05/2012
9	Infections 05/2021 - 01/2012
6	Pneumonia (Pneumonitis) 10/2020 - 10/2012
5	COVID-19 01/2022 - 10/2020
3	Septic Shock (Toxic Shock Syndrome) 01/2022 - 07/2013
3	Ventilator-Associated Pneumonia 05/2021 - 08/2013
2	Fibrosis (Cirrhosis) 01/2022 - 03/2019
2	Thrombosis (Thrombus) 01/2022 - 10/2020
2	Critical Illness (Critically Ill) 05/2021 - 10/2020
2	Human Influenza (Influenza) 10/2020 - 11/2012
2	Venous Thrombosis (Deep-Vein Thrombosis) 10/2020 - 01/2020
2	Thrombocytopenia (Thrombopenia) 10/2020 - 01/2020
2	Pulmonary Embolism 10/2020 - 07/2020
2	Healthcare-Associated Pneumonia 11/2018 - 02/2018
2	Cross Infection (Nosocomial Infection) 11/2017 - 06/2015
2	Paralysis (Palsy) 07/2017 - 02/2015
1	Dyspnea (Shortness of Breath) 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022
1	Hypersensitivity (Allergy) 07/2021
1	Body Weight (Weight, Body) 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Patient-Ventilator Asynchrony 12/2020
1	Cardiogenic Shock 10/2020
1	Hypertension (High Blood Pressure) 10/2020
1	Chronic Renal Insufficiency 10/2020
1	Acute Kidney Injury (Acute Renal Failure) 10/2020
1	Venous Thromboembolism 10/2020
1	Primary Graft Dysfunction 01/2020
1	Hyperthyroidism 01/2020
1	Thyroid Crisis (Thyrotoxic Crisis) 01/2020
1	Thyrotoxicosis 01/2020
1	Bacterial Pneumonia 01/2020
1	Graves Disease (Basedow Disease) 01/2020
1	Measles 11/2018
1	Reinfection 12/2017
1	Heart Arrest (Cardiac Arrest) 08/2017
1	Burns 01/2015
1	Pseudomonas Infections 01/2015
1	Cystic Fibrosis (Mucoviscidosis) 01/2015
1	Respiratory Tract Infections (Respiratory Tract Infection) 11/2014
1	Pulmonary Edema 07/2013
1	Hypoxia (Hypoxemia) 07/2013
1	Renal Insufficiency (Renal Failure) 07/2013
1	Shock 07/2013
1	Respiratory Insufficiency (Respiratory Failure) 01/2013
1	Invasive Pulmonary Aspergillosis 11/2012

Drug/Important Bio-Agent (IBA)

8	Neuromuscular Blocking AgentsIBA 12/2020 - 10/2012
3	Antiviral Agents (Antivirals)IBA 01/2021 - 07/2020
3	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2018 - 07/2013
2	Oxygen (Dioxygen)IBA 01/2022 - 01/2019
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2020 - 05/2020
2	procollagen Type III-N-terminal peptide (PIIP)IBA 03/2019 - 01/2015
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 07/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2014 - 08/2013
2	Colistin (Coly-Mycin)FDA Link 10/2013 - 10/2012
2	Pharmaceutical PreparationsIBA 08/2013 - 10/2012
1	Fibrinolysin FDA Link 01/2022
1	beta-LactamsIBA 07/2021
1	LactamsIBA 07/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2021
1	SteroidsIBA 01/2021
1	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 10/2020
1	Toll-Like Receptor 3IBA 10/2020
1	Interferon Type IIBA 10/2020
1	remdesivirIBA 10/2020
1	Ritonavir (Norvir)FDA Link 10/2020
1	Lopinavir FDA Link 10/2020
1	Heparin (Liquaemin)FDA LinkGeneric 10/2020
1	Prothrombin (Factor II)IBA 10/2020
1	lopinavir-ritonavir drug combination (Kaletra)FDA Link 05/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 05/2020
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2020
1	Antithyroid Agents (Antithyroid Drugs)IBA 01/2020
1	ProcollagenIBA 03/2019
1	Biomarkers (Surrogate Marker)IBA 03/2019
1	Almitrine (Vectarion)IBA 01/2019
1	ChlorhexidineIBA 06/2015
1	Therapeutic UsesIBA 01/2014
1	EnzymesIBA 01/2014
1	Acyl-ButyrolactonesIBA 01/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2013
1	AlbuminsIBA 07/2013
1	galactomannanIBA 11/2012
1	AntigensIBA 11/2012
1	squalamineIBA 10/2012

Therapy/Procedure

11	Artificial Respiration (Mechanical Ventilation) 07/2021 - 05/2012
8	Therapeutics 10/2020 - 10/2013
6	Extracorporeal Membrane Oxygenation 10/2020 - 01/2014
3	Length of Stay 01/2022 - 01/2021
3	Critical Care (Surgical Intensive Care) 01/2022 - 02/2018
3	Lung Transplantation 01/2021 - 12/2017
3	Mechanical Ventilators (Ventilator) 10/2020 - 01/2012
3	Cannula 10/2020 - 11/2017
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2021
1	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2020
1	Central Venous Catheters 10/2020
1	Oxygenators 10/2020
1	Transplantation 01/2020
1	Anesthesia 02/2018
1	Noninvasive Ventilation 08/2017